Upgrade to SI Premium - Free Trial

Corvus Pharma (CRVS)

13.11 +0.20 (1.55%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26)

Latest Headlines

Corvus Pharmaceuticals publishes soquelitinib Phase 1 T cell data in Blood August 27, 2026 7:30 AM - StreetInsider Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial August 27, 2026 7:30 AM - Globe NewsWire Form SCHEDULE 13G Corvus Pharmaceuticals, Filed by: STATE STREET CORP August 7, 2026 9:17 AM - SEC Filing Corvus Pharmaceuticals, Inc. (CRVS) Misses Q2 EPS by 4c August 6, 2026 5:55 PM - StreetInsider Form 10-Q Corvus Pharmaceuticals, For: Jun 30 August 6, 2026 4:06 PM - SEC Filing Form 8-K Corvus Pharmaceuticals, For: Aug 06 August 6, 2026 4:03 PM - SEC Filing Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results August 6, 2026 4:01 PM - Globe NewsWire Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026 July 30, 2026 4:01 PM - Globe NewsWire Ladenburg Thalmann Assumes Corvus Pharmaceuticals (CRVS) at Buy July 29, 2026 12:26 PM - StreetInsider Form SCHEDULE 13G/A Corvus Pharmaceuticals, Filed by: BlackRock, Inc. July 27, 2026 4:28 PM - SEC Filing Form 8-K Corvus Pharmaceuticals, For: Jul 21 July 22, 2026 4:02 PM - SEC Filing Full Article List